The latest SOTC write up is nothing more than updated Anavex propaganda. The mission of SOTC says: SOTC Analytics strives to report medical intelligence pertaining to neurodegenerative & neurodevelopmental disorders to include Alzheimer's Disease, Parkinson's Disease, Rett Syndrome, Angelman Syndrome, Fragile X, and more.
We follow ongoing trends in clinical research, recap important peer-reviewed medical journals, and chronicle ongoing events at Anavex Life Sciences corp. ($AVXL), which we believe may have the most promising emerging therapeutics cross-central nervous system (CNS).
Really? Jesse reports on medical intelligence? Read the site. The only intelligence he reports on pertains to Anavex.
They “follow” ongoing trends in clinical research. Really? Like whose? Again, it’s all Anavex all the time.
How about this from the Little Memories page:
This page exists to contain brief reports on emerging sciences related to lifestyle, genomics, disease, and therapies. These reports will not be driven toward any specific company or therapy. You should consult your physician before implementing any lifestyle or health suggestions within these reports.
Stay Tuned
This site has been up since 2022. How long does it take to add in brief reports…
Jesse has a background in defense intelligence. No doubt he’s smart but he knows nothing about medical science. I don’t see doc328 writing reports on space-based spying technology.
Again, it’s nothing more than Anavex propaganda. There isn’t even a shred of skepticism about anything related to Anavex.
Anyone basing their investment decisions on SOTC’s perfect world of Anavex should have their head examined.
News 
Market Data 
Discover 
